DEFAZIO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 7.056
EU - Europa 884
AS - Asia 386
OC - Oceania 1
SA - Sud America 1
Totale 8.328
Nazione #
US - Stati Uniti d'America 7.046
CN - Cina 356
UA - Ucraina 235
SE - Svezia 189
DE - Germania 168
FI - Finlandia 144
GB - Regno Unito 61
IT - Italia 40
BE - Belgio 14
IR - Iran 14
IN - India 12
IE - Irlanda 11
CA - Canada 9
RU - Federazione Russa 9
FR - Francia 6
BD - Bangladesh 3
AU - Australia 1
BG - Bulgaria 1
CO - Colombia 1
GR - Grecia 1
HU - Ungheria 1
ME - Montenegro 1
MX - Messico 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
Totale 8.328
Città #
Fairfield 1.164
Woodbridge 905
Houston 549
Jacksonville 530
Chandler 515
Ashburn 481
Seattle 473
Cambridge 398
Wilmington 350
Ann Arbor 332
Roxbury 138
Lawrence 137
Nanjing 137
Nyköping 96
Des Moines 90
New York 81
Princeton 79
Boardman 61
Beijing 49
San Diego 45
Shenyang 40
Nanchang 35
Hebei 34
Inglewood 33
Jiaxing 23
Bari 16
San Mateo 16
Brussels 14
Changsha 14
Dublin 11
Los Angeles 11
Augusta 10
Norwalk 10
Leawood 9
London 9
Ardabil 8
Helsinki 7
Pune 7
Tianjin 7
Brooklyn 5
Falls Church 5
Monmouth Junction 5
Toronto 5
Washington 5
Dearborn 4
Zhengzhou 4
Auburn Hills 3
Formia 3
Ningbo 3
Paris 3
Sabz 3
St Petersburg 3
Acton 2
Edinburgh 2
Frankfurt am Main 2
Genoa 2
Grafing 2
Kish 2
Kunming 2
Kyiv 2
Montréal 2
Mumbai 2
Ostuni 2
Prescot 2
Redmond 2
Taizhou 2
Taranto 2
Amsterdam 1
Athens 1
Athol 1
Bogotá 1
Brantford 1
Budapest 1
Chiswick 1
Conversano 1
Cottbus 1
Guangzhou 1
Hefei 1
Indiana 1
Islington 1
Istanbul 1
Jinan 1
Jincheng 1
Kraków 1
Montreal 1
Mountain View 1
Nizhny Tagil 1
Oswestry 1
Palermo 1
Podgorica 1
Redwood City 1
Richmond 1
Rome 1
Saint Petersburg 1
Sofia 1
Stockholm 1
Sydney 1
Totale 7.035
Nome #
Bilateral striatal necrosis, dystonia and multiple mitochondrial DNA deletions: case study and effect of deep brain stimulation 123
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 106
No association between essential tremor and migraine: A case-control study 102
A comparative study of primary and secondary hemifacial spasm 97
Relationship between eye symptoms and blepharospasm: a multicenter case-control study 96
Onset and spread of dyskinesias and motor symptoms in Parkinson's disease 93
Frequency of familial aggregation in primary adult-onset cranial cervical dystonia 93
Brain F-18 Fluorocholine PET/CT for the Assessment of Optic Pathway Glioma in Neurofibromatosis-1 91
Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment 90
Camptocormia in Parkinson disease: an epidemiological and clinical study 90
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. 90
Antineuronal antibody status and phenotype analysis in Tourette's syndrome 89
L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?. 88
null 88
Headache in cranial and cervical dystonia 87
Are nongenetic triggers for dystonia type-specific? A study exploring scoliosis in blepharospasm 85
The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia 84
Antineuronal antibodies in cranial dystonia. 84
The natural history of treated PD in an incident, community-based cohort: does the future begin? 84
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 84
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders 83
Post-streptococcal 'complex' movement disorders: unusual concurrence of psychogenic and organic symptoms 83
Anti-basal ganglia antibodies and Tourette's syndrome: a voxel-based morphometry and diffusion tensor imaging study in an adult population 83
Development and validation of a clinical guideline for diagnosing blepharospasm 82
Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing 80
Cortical gray matter changes in primary blepharospasm: a voxel-based morphometry study 79
EPIDEMIOLOGY OF PRIMARY BLEPHAROSPASM 78
Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease 78
Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia? 77
Epidemiology of primary and secondary dystonia 76
Pain and motor complications in Parkinson's disease 75
Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture 75
Psychiatric disorders in patients with essential tremor 75
Sleep and cranial dystonia 74
Endocytosis of horseradish peroxidase by brain microvascular and umbilical vein endothelial cells in culture: an ultrastructural and morphometric study 74
Abnormal tactile temporal discrimination in psychogenic dystonia 74
Quality of sleep in primary focal dystonia: a case-control study 72
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia 71
A family study on primary blepharospasm 71
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 71
Temporal discrimination in patients with dystonia and tremor and patients with essential tremor 70
Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm 70
null 70
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias 70
Ataxia in posterior circulation stroke: clinical-MRI correlations 70
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a 70
Time processing in children with Tourette's syndrome 69
Is increased blinking a form of blepharospasm? 69
The epidemiology of primary dystonia: current evidence and perspectives 69
Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials 69
Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials 69
Mirror movements in patients with Parkinson's disease 69
Botulinum A toxin for the so-called apraxia of lid opening 69
Epidemiology of primary dystonia 68
How pain arises in Parkinson's disease 68
Epidemiology of primary and secondary dystonia 67
Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria . 67
Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene 67
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 67
Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group 67
Eye symptoms in relatives of patients with primary adult-onset dystonia 66
The epidemiology of pain in Parkinson's disease 65
Long-term assessment of the risk of spread in primary late-onset focal dystonia 65
Do primary adult-onset focal dystonias share aetiological factors? 65
Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia 65
Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening 65
Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia 65
Soluble adhesion molecules in Gilles de la Tourette's syndrome 64
The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder 64
Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24) 64
null 63
Tracing Sydenham's chorea: historical documents from a British paediatric hospital 62
The influence of electroencephalographic focus laterality on efficacy of carbamazepine in complex partial and secondarily generalized tonic-clonic seizures 62
Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture 62
Primary Cervical dystonia and scoliosis: a multicenter case-control study 62
Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials 61
Sensitivity and specificity of a self-administered questionnaire for familial screening of adult-onset dystonia 61
Influence of age on the association between primary hemifacial spasm and arterial hypertension 61
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions 61
Fatigue in Parkinson's disease 61
Pathophysiology of somatosensory abnormalities in Parkinson disease. 60
null 60
"Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report 59
Impaired cognitive functions in adult-onset primary cranial cervical dystonia 58
Head trauma in primary cranial dystonias: a multicentre case-control study 58
Temporal expectation in focal hand dystonia 57
Cortical excitability is abnormal in patients with the "fixed dystonia" syndrome 57
Toxicity of fungicides containing ethylene-bis-dithiocarbamate in serumless dissociated mesencephalic-striatal primary coculture 55
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia 55
Speech-induced blepharospasm 55
The environmental epidemiology of primary dystonia 54
Corpus Striatum 52
Facial dystonia: clinical features, prognosis and pharmacology in 31 patients 52
Holmes' tremor associated to HSV-1 cerebral pedunculitis: a case report 52
Prevalence of primary blepharospasm in a community of Puglia region, southern Italy 51
Menopause and menarche in patients with primary blepharospasm: an exploratory case-control study 51
Neurological research in Italy in 2003 and 2004 49
Serum IgG to brain microvascular endothelial cells in multiple sclerosis 49
Planning genetic studies on primary adult-onset dystonia: sample size estimates based on examination of first-degree relatives 49
Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses 49
Totale 7.095
Categoria #
all - tutte 27.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019866 0 0 0 0 0 0 0 0 0 0 453 413
2019/20202.643 470 175 99 284 303 167 262 230 319 95 181 58
2020/20211.309 135 94 150 68 113 64 100 94 121 172 128 70
2021/2022758 35 54 0 28 47 78 21 35 90 78 127 165
2022/20231.199 229 88 28 141 187 159 3 120 183 2 32 27
2023/2024425 40 95 13 111 24 119 0 13 2 8 0 0
Totale 8.366